PHARMALUX: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMALUX
Largest movements
- Cash -€72,436
down €72,436 (-25.5%), from €284,120 to €211,684
mainly Net result for the year (-€43,360) and Receivables within one year (-€26,284)
- Receivables within one year +€26,284
up €26,284 (+8.4%), from €313,365 to €339,649
of which Trade receivables: +€24,436
- Reserves -€43,500
down €43,500 (-4.2%), from €1.0m to €980,300
of which Distributable reserves: -€43,500
- Staff costs +€26,063
up €26,063 (+21.0%), from €124,327 to €150,390
- Gross operating margin -€14,249
down €14,249 (-11.3%), from €125,885 to €111,636
- Financial charges +€4,695
up €4,695 (+163%), from €2,879 to €7,574
- Taxes -€3,753
down €3,753 (-100%), from €3,753 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,426,488 | €1,385,266 | -€41,222 | -2.9% |
| Fixed assets | 21/28 | €724,233 | €732,498 | +€8,265 | +1.1% |
| Tangible fixed assets | 22/27 | €6,271 | €14,536 | +€8,265 | +132% |
| Plant, machinery and equipment | 23 | €6,029 | €13,635 | +€7,606 | +126% |
| Furniture and vehicles | 24 | €242 | €901 | +€659 | +272% |
| Financial fixed assets | 28 | €717,962 | €717,962 | = | 0.0% |
| Current assets | 29/58 | €702,255 | €652,769 | -€49,487 | -7.0% |
| Stocks and contracts in progress | 3 | €87,398 | €85,113 | -€2,285 | -2.6% |
| Stocks | 30/36 | €87,398 | €85,113 | -€2,285 | -2.6% |
| Amounts receivable within one year | 40/41 | €313,365 | €339,649 | +€26,284 | +8.4% |
| Trade receivables | 40 | €65,861 | €90,297 | +€24,436 | +37.1% |
| Other amounts receivable | 41 | €247,504 | €249,352 | +€1,848 | +0.7% |
| Cash at bank and in hand | 54/58 | €284,120 | €211,684 | -€72,436 | -25.5% |
| Deferred charges and accrued income | 490/1 | €17,372 | €16,323 | -€1,049 | -6.0% |
| Total equity and liabilities | 10/49 | €1,426,488 | €1,385,266 | -€41,222 | -2.9% |
| Equity | 10/15 | €1,309,425 | €1,266,065 | -€43,360 | -3.3% |
| Contributions | 10/11 | €285,460 | €285,460 | = | 0.0% |
| Reserves | 13 | €1,023,800 | €980,300 | -€43,500 | -4.2% |
| Non-distributable reserves | 130/1 | €107,300 | €107,300 | = | 0.0% |
| Reserves not available under the articles | 1311 | €107,300 | €107,300 | = | 0.0% |
| Distributable reserves | 133 | €916,500 | €873,000 | -€43,500 | -4.7% |
| Profit (loss) carried forward | 14 | €165 | €304 | +€140 | +84.8% |
| Amounts payable | 17/49 | €117,063 | €119,202 | +€2,138 | +1.8% |
| Amounts payable within one year | 42/48 | €114,471 | €116,810 | +€2,339 | +2.0% |
| Trade debts | 44 | €63,094 | €55,564 | -€7,530 | -11.9% |
| Suppliers | 440/4 | €63,094 | €55,564 | -€7,530 | -11.9% |
| Taxes, remuneration and social security | 45 | €18,955 | €26,988 | +€8,033 | +42.4% |
| Taxes | 450/3 | €0 | €6,553 | +€6,553 | |
| Remuneration and social security | 454/9 | €18,955 | €20,435 | +€1,480 | +7.8% |
| Other amounts payable | 47/48 | €32,422 | €34,258 | +€1,837 | +5.7% |
| Accrued charges and deferred income | 492/3 | €2,592 | €2,391 | -€201 | -7.7% |
| Remuneration, social security and pensions | 62 | €124,327 | €150,390 | +€26,063 | +21.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,236 | €3,690 | +€454 | +14.0% |
| Other operating charges | 640/8 | €1,204 | €1,238 | +€35 | +2.9% |
| Gross operating margin | 9900 | €125,885 | €111,636 | -€14,249 | -11.3% |
| Operating profit (loss) | 9901 | -€2,881 | -€43,682 | -€40,801 | -1,416% |
| Financial income | 75/76B | €8,852 | €7,896 | -€956 | -10.8% |
| Recurring financial income | 75 | €8,852 | €7,896 | -€956 | -10.8% |
| Financial charges | 65/66B | €2,879 | €7,574 | +€4,695 | +163% |
| Recurring financial charges | 65 | €2,879 | €7,574 | +€4,695 | +163% |
| Profit (loss) for the period before taxes | 9903 | €3,092 | -€43,360 | -€46,452 | |
| Income taxes | 67/77 | €3,753 | €0 | -€3,753 | -100% |
| Profit (loss) for the period | 9904 | -€662 | -€43,360 | -€42,699 | -6,454% |
| Profit (loss) for the period to be appropriated | 9905 | -€662 | -€43,360 | -€42,699 | -6,454% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.